Filing Details

Accession Number:
0001387131-21-005565
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-12 13:00:00
Reporting Period:
2021-05-10
Accepted Time:
2021-05-12 20:36:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
25743 Therapeuticsmd Inc. TXMD Pharmaceutical Preparations (2834) 870233535
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1532235 G Robert Finizio 951 Yamato Road, Suite 220
Boca Raton FL 33431
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-10 158,334 $0.00 18,059,334 No 4 M Direct
Common Stock Disposition 2021-05-11 67,697 $1.04 17,991,637 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2021-05-10 158,334 $0.00 158,334 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
316,666 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,000,000 Indirect See Footnote
Footnotes
  1. On May 10, 2021, the reporting person received 158,334 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.
  2. The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
  3. The reported securities are held by the Robert Finizio Revocable Trust.
  4. Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
  5. The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.